Tests, Therapies & Services Conflicts of Interest Statement
Why is this important? There is a potential for people to exaggerate or unfairly focus on the benefits or risks of tests, therapies or services when they can profit professionally or financially from this information. It is Good Business Practice to declare conflicts of interest.
Where there is a conflict of interest, these people have no involvement in the research, inclusion or design of conflicted content in Longevity.School. Longevity.School's conflict of interest policy maintains the fully independent nature of our content.
William Baines
Holds equity in FiveAlarmBio senescent cell startup where he is CSO
Leon Apel
Holds equity in various pre-commercial rejuvenation biotechnology companies
Bill Cherman
Holds equity in various pre-commercial rejuvenation biotechnology companies, including Dante Labs
Oliver Zolman
Holds equity in Dante Labs consumer whole genome sequencing company
Aubrey de Grey
VP at AgeX Therapeutics
Try Longevity.School for free
Resources
Channels
Customer Reviews
Customer Interviews
Livestream Q&As
Privacy & Terms | Contact
Copyright 2016-2020 20one Consulting Ltd.
UK Registration: 10299987
ICO Registration: ZA297182
Legal
Products and Services do not provide medical advice. Do not make any changes to your health behaviours without consulting your licensed clinicians first. See the medical disclaimer within the terms and conditions.
Oliver Zolman does not see patients and does not give medical advice. The contents on this site and his related Products & Services are for health informational purposes only, not medical advice
.